Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Castello

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 10, 2019
Response assessment of bone metastatic disease: seeing the forest for the trees RECIST, PERCIST, iRECIST, and PCWG-2Angelo Castello, Egesta Lopci
European Journal of Nuclear Medicine and Molecular Imaging|December 16, 2017
Incidental identification of osteoid osteoma by <sup>68</sup>Ga-PSMA PET/CTAngelo Castello, Egesta Lopci
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 29, 2020
Update on tumor metabolism and patterns of response to immunotherapyAngelo Castello, Egesta Lopci
Current Radiopharmaceuticals|November 22, 2019
The Role of PET/CT in the Era of Immune Checkpoint Inhibitors: State of ArtAngelo Castello, Egesta Lopci
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
Reply: Diagnosis of Hyperprogressive Disease in Patients Treated with Checkpoint Inhibitors Using <sup>18</sup>F-FDG PET/CTAngelo Castello, Egesta Lopci
Revista Espanola De Medicina Nuclear E Imagen Molecular|July 5, 2021
Peritoneal carcinomatosis and occult metastasis in prostate cancer: [<sup>68</sup>Ga]PSMA vs [<sup>11</sup>C]CholineAngelo Castello, Paola Caroli, Egesta Lopci
Seminars in Nuclear Medicine|November 11, 2023
PSMA PET/CT Versus mpMRI for the Detection of Clinically Significant Prostate Cancer: An Updated OverviewMatteo Caracciolo, Angelo Castello, Egesta Lopci
European Journal of Nuclear Medicine and Molecular Imaging|March 14, 2018
Is it time to change our vision of tumor metabolism prior to immunotherapy?Fabio Grizzi, Angelo Castello, Egesta Lopci
Nuclear Medicine Review. Central & Eastern Europe|August 12, 2020
Multimodality imaging of ectopic focus in Graves' DiseaseEgesta Lopci, Angelo Castello, Emanuela Mazziotti
Endocrine|August 18, 2015
Interventricular septum metastasis in neuroendocrine tumourAngelo Castello, Vittorio Briganti, Roberto Sciagrà
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 10, 2019
Response assessment of bone metastatic disease: seeing the forest for the trees RECIST, PERCIST, iRECIST, and PCWG-2Angelo Castello, Egesta Lopci
European Journal of Nuclear Medicine and Molecular Imaging|December 16, 2017
Incidental identification of osteoid osteoma by <sup>68</sup>Ga-PSMA PET/CTAngelo Castello, Egesta Lopci
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 29, 2020
Update on tumor metabolism and patterns of response to immunotherapyAngelo Castello, Egesta Lopci
Current Radiopharmaceuticals|November 22, 2019
The Role of PET/CT in the Era of Immune Checkpoint Inhibitors: State of ArtAngelo Castello, Egesta Lopci
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
Reply: Diagnosis of Hyperprogressive Disease in Patients Treated with Checkpoint Inhibitors Using <sup>18</sup>F-FDG PET/CTAngelo Castello, Egesta Lopci
Revista Espanola De Medicina Nuclear E Imagen Molecular|July 5, 2021
Peritoneal carcinomatosis and occult metastasis in prostate cancer: [<sup>68</sup>Ga]PSMA vs [<sup>11</sup>C]CholineAngelo Castello, Paola Caroli, Egesta Lopci
Seminars in Nuclear Medicine|November 11, 2023
PSMA PET/CT Versus mpMRI for the Detection of Clinically Significant Prostate Cancer: An Updated OverviewMatteo Caracciolo, Angelo Castello, Egesta Lopci
European Journal of Nuclear Medicine and Molecular Imaging|March 14, 2018
Is it time to change our vision of tumor metabolism prior to immunotherapy?Fabio Grizzi, Angelo Castello, Egesta Lopci
Nuclear Medicine Review. Central & Eastern Europe|August 12, 2020
Multimodality imaging of ectopic focus in Graves' DiseaseEgesta Lopci, Angelo Castello, Emanuela Mazziotti
Endocrine|August 18, 2015
Interventricular septum metastasis in neuroendocrine tumourAngelo Castello, Vittorio Briganti, Roberto Sciagrà
Pageof 8